Isolation and identification of the human homolog of a new p53-binding protein, Mdmx

Genomics

Volumn 43, Issue 1, 1997, Pages 34-42

  Shvarts, Avi ^a,b   Bazuine, Merlijn ^b   Dekker, Patrick ^b   Ramos, Yolande F M ^b   Steegenga, Wilma T ^b   Merckx, Gerard ^c   Van Ham, Reinier C A ^b   Van Der Houven Van Oordt, Willemien ^b   Van Der Eb, Alex J ^b   Jochemsen, A G ^b  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; COMPLEMENTARY DNA; PROTEIN P53;

ARTICLE; CHROMOSOME 1; CHROMOSOME 1Q; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ISOLATION; SEQUENCE HOMOLOGY;

EID: 0031194666     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.1997.4775     Document Type: Article

References (47)

1. Annweiler, A., Hipskind, R. A., and Wirth, T. (1991). A strategy for efficient in vitro translation of cDNAs using the rabbit beta-globin leader sequence. Nucleic Acids Res. 19: 3750.
2. Barak, Y., Gottlieb, E., Juven-Gershon, T., and Oren, M. (1994). Regulation of mdm2 expression by p53: Alternative promoters produce transcripts with nonidentical translation potential. Genes Dev. 8: 1739-1749.
3. Barak, Y., and Oren, M. (1992). Enhanced binding of a 95-kda protein to p53 in cells undergoing p53-mediated growth arrest. EMBO J. 11: 2115-2121.
4. Boddy, M. N., Freemont, P. S., and Borden, K. L. B. (1994). The p53-associated protein MDM2 contains a newly characterized zinc binding domain called the RING finger. Trends. Biochem. Sci. 19: 198-199.
5. Brown, D. R., Deb, S., Munoz, R. M., Subler, M. A., and Deb, S. P. (1993). The tumor suppressor p53 and the oncoprotein simian virus-40 T-antigen bind to overlapping domains on the mdm2 protein. Mol. Cell. Biol. 13: 6849-6857.
6. Bueso-Ramos, C. E., Yang, Y., DeLeon, E., McCown, P., Stass, S. A., and Albitar, M. (1993). The human MDM-2 oncogene is overexpressed in leukemias. Blood 82: 2617-2623.
7. Chen, J. D., Lin, J. Y., and Levine, A. J. (1995). Regulation of transcription functions of the p53 tumor suppressor by the mdm-2 oncogene. Mol. Med. 1: 142-152.
8. Corvi, R., Savelyeva, L., Breit, S., Wenzel, A., Handgretinger, R., Barak, J., Oren, M., Amler, L., and Schwab, M. (1995). Non-syntenic amplification of MDM2 and MYCN in human neuroblastoma. Oncogene 10: 1081-1108.
9. Feitelson, M. A., Zhu, M., Duan, L. X., and London, W. T. (1993). Hepatitis B X antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma. Oncogene 8: 1109-1117.
10. Forus, A., Olde Weghuis, D., Smeets, D., Fodstad, O., Myklebost, O., and Geurts van Kessel, A. (1995). Comparative genomic hybridization analysis of human sarcomas. I. Occurrence of genomic imbalances and identification of a novel major amplicon at 1q21-q22 in soft tissue sarcomas. Genes Chromosomes Cancer 14: 8-14.
11. Francis, F., Zehetner, G., Hoglund, M., and Lehrach, H. (1994). Construction and analysis of the ICRF human P1 library. Genet. Anal. Tech. Appl. 11: 5-6.
12. Habuchi, T., Kinoshita, H., Yamada, H., Kakehi, Y., Ogawa, O., Wu, W. J., Takahashi, R., Sugiyama, T., and Yoshida, O. (1994). Oncogene amplification in urothelial cancers with p53 gene mutation or MDM2 amplification. J Natl. Cancer Inst. 86: 1331-1335.
13. Haines, D. S., Landers, J. E., Engle, L. J., and George, D. L. (1994). Physical and functional interaction between wild-type p53 and mdm2 proteins. Mol. Cell. Biol. 14: 1171-1178.
14. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C. C. (1991). p53 mutations in human cancers. Science 253: 49-53.
15. Hollstein, M., Rice, K., Greenblatt, M. S., Soussi, T., Fuchs, R., Sorlie, T., Hovig, E., Smith-Sorensen, B., Montesano, R., and Harris, C. C. (1994). Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res. 22: 3551-3555.
16. Jones, S. N., Ansarilari, M. A., Hancock, A. R., Jones, W. J., Gibbs, R. A., Donehower, L. A., and Bradley, A. (1996). Genomic organization of the mouse double minute 2 gene. Gene 175: 209-213.
17. Ladanyi, M., Lewis, R., Jhanwar, S. C., Gerald, W., Huvos, A. G., and Healey, J. H. (1995). MDM2 and CDK4 gene amplification in Ewing's sarcoma. J. Pathol. 175: 211-217.
18. Lane, D. P., and Crawford, L. V. (1979). T antigen is bound to a host protein in SV40-transformed cells. Nature 278: 261-263.
19. Lianes, P., Orlow, I., Zhang, Z. F., Oliva, M. R., Sarkis, A. S., Reuter, V. E., and Cordoncardo, C. (1994). Altered patterns of MDM2 and TP53 expression in human bladder cancer. J Natl. Cancer Inst. 86: 1325-1330.
20. Linzer, D. I., and Levine, A. J. (1979). Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell 17: 43-52.
21. Lyon, M. F., and Searle, A. G. (Eds.) (1989). "Genetic Variants and Strains of the Laboratory Mouse," Second ed., Oxford Univ. Press, Oxford/Gustav Fischer Verlag, Stuttgart.
22. Maestro, R., Gloghini, A., Doglioni, C., Gasparotto, D., Vukosavljevic, T., Dere, V., Laurino, L., Carbone, A., and Boiocchi, M. (1995). MDM2 overexpression does not account for stabilization of wildtype p53 protein in non-hodgkin's lymphomas. Blood 85: 3239-3246.
23. Maheswaran, S., Park, S., Bernard, A., Morris, J. F., Rauscher, F. J., Hill, D. E., and Haber, D. A. (1993). Physical and functional interaction between WT1 and p53 proteins. Proc. Natl. Acad. Sci. USA 90: 5100-5104.
24. Martin, K., Trouche, D., Hagemeier, C., Sorensen, T. S., La Thangue, N. B., and Kouzarides, T. (1995). Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein. Nature 375: 691-694.
25. Moll, U. M., LaQuaglia, M., Benard, J., and Riou, G. (1995). Wildtype p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors. Proc. Natl. Acad. Sci. USA 92: 4407-4411.
26. Moll, U. M., Riou, G., and Levine, A. J. (1992). Two distinct mechanisms alter p53 in breast cancer: Mutation and nuclear exclusion. Proc. Natl. Acad. Sci. USA 89: 7262-7266.
27. Montes de Oca Luna, R., Tabor, A. D., Eberspaecher, H., Hulboy, D. L., Worth, L. L., Colman, M. S., Finlay, C. A., and Lozano, G. (1996). The organization and expression of the mdm2 gene. Genomics 33: 352-357.
28. Momand, J., Zambetti, G. P., Olson, D. C., George, D., and Levine, A. J. (1992). The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69: 1237-1245.
29. O'Connor, D. J., Lam, E. W. F., Griffin, S., Zhong, S., Leighton, L. C., Burbidge, S. A., and Lu, X. (1995). Physical and functional interactions between p53 and cell cycle co-operating transcription factors, E2F1 and DP1. EMBO J. 14: 6184-6192.
30. Oliner, J. D., Kinzler, K. W., Meltzer, P. S., George, D. L., and Vogelstein, B. (1992). Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 358: 80-83.
31. Oliner, J. D., Pietenpol, J. A., Thiagalingam, S., Gyuris, J., Kinzler, K. W., and Vogelstein, B. (1993). Oncoprotein MDM2 conceals the activation domain of tumour suppressor-p53. Nature 362: 857-860.
32. Reifenberger, G., Liu, L., Ichimura, K., Schmidt, E. E., and Collins, V. P. (1993). Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations. Cancer Res. 53: 2736-2739.
33. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989). "Molecular Cloning: A Laboratory Manual," Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
34. Sarnow, P., Ho, Y. S., Williams, J., and Levine, A. J. (1982). Adenovirus E1b-58 kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells. Cell 28: 387-394.
35. Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., and Howley, P. M. (1990). The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63: 1129-1136.
36. Shvarts, A., Steegenga, W. T., Riteco, N., Van Laar, T., Dekker, P., Bazuine, M., Van Ham, R. C. A., Van der Houven van Oordt, W., Hateboer, G., Van der Eb, A. J., and Jochemsen, A. G. (1996). MDMX: A novel p53 binding protein with some functional properties of MDM2. EMBO J. 15: 5349-5357.
37. Smith, D. B., and Johnson, K. S. (1988). Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 67: 31-40.
38. Srivastava, S., Tong, Y. A., Devadas, K., Zou, Z. Q., Chen, Y., Pirollo, K. F., and Chang, E. H. (1992). The status of the p53 gene in human papilloma virus positive or negative cervical carcinoma cell lines. Carcinogenesis 13: 1273-1275.
39. Steegenga, W. T., Shvarts, A., Van Laar, T., Van der Eb, A. J., and Jochemsen, A. G. (1995). Altered phosphorylation and oligomerization of p53 in adenovirus type 12-transformed cells. Oncogene 11: 49-57.
40. Steegenga, W. T., Van Laar, T., Riteco, N., Mandarine, A., Shvarts, A., van der Eb, A. J., and Jochemsen, A. G. (1996). Adenovirus E1A proteins inhibit activation of transcription by p53. Mol. Cell. Biol. 16.
41. Szymanska, J., Tarkkanen, M., Wiklund, T., Virolainen, M., Blomqvist, C., Askoseljavaara, S., Tukiainen, E., Elomaa, I., and Knuutila, S. (1996). Gains and losses of DNA sequences in liposarcomas evaluated by comparative genomic hybridization. Genes Chromosomes Cancer 15: 89-94.
42. Ueda, H., Ullrich, S. J., Gangemi, J. D., Kappel, C. A., Ngo, L., Feitelson, M. A., and Jay, G. (1995). Functional inactivation but not structural mutation of p53 causes liver cancer. Nature Genet. 9: 41-47.
43. Weissman, B. E., Saxon, P. J., Pasqaule, S. R., Jones, G. R., Geiser, A. G., and Stanbridge, E. J. (1987). Introduction of a normal human chromosome 11 into a Wilms' tumor cell line controls its tumorigenic expression. Science 236: 175-180.
44. Werness, B. A., Levine, A. J., and Howley, P. M. (1990). Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248: 76-79.
45. Zantema, A., Schrier, P. I., Davis-Olivier, A., Van Laar, T., Vaessen, R. T. M. J., and van der Eb, A. J. (1985). Adenovirus serotype determines association and localization of the large E1B tumor antigen with cellular tumor antigen p53 in transformed cells. Mol. Cell. Biol. 5: 3084-3091.
46. Zauberman, A., Flusberg, D., Haupt, Y., Barak, Y., and Oren, M. (1995). A functional p53-responsive intronic promoter is contained within the human mdm2 gene. Nucleic Acids Res. 23: 2584-2592.
47. Zhou, M., Yeager, A. M., Smith, S. D., and Findley, H. W. (1995). Overexpression of the MDM2 gene by childhood acute lymphoblastic leukemia cells expressing the wild-type p53 gene. Blood 85: 1608-1614.